Generic Name |
Pembrolizumab | |
---|---|---|
IND |
MK-3475 | |
Brand Name (US) |
Keytruda | |
Manufacturer |
Merck | |
Drug Type |
Anti-PD-1 antibody | |
Delivery |
Intravenous | |
Approval Status |
Approved for a non-GIST application | |
Indications |
Melanoma | |
Overall Strategy |
Immune system | |
Strategy |
Stimulate the immune system | |
Drug Category |
PD-1 inhibitor |
Links |
|
|
Prescribing information |
|
Keytruda website |
Trials of this drug |
|
Trial results |